Clinical Trials Logo

Clinical Trial Summary

The risk-benefit of surveillance-protocol biopsy (SPBx) in kidney transplantation remains unclear. The study aims to compare outcomes of recipients with SPBx approach to recipients with standard approach which allograft biopsy was performed only when indicated.


Clinical Trial Description

The present randomized-controlled trial in kidney transplant patients aims to compare the outcomes and complications between who underwent immunosuppessive drug modification under surveillance-protocol biopsy and who underwent immunosuppressive drug modification following tough level only. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02294097
Study type Interventional
Source Chulalongkorn University
Contact Wiwat Chancharoenthana, MD., MSc.
Phone +66 22564251
Email wiwatmd@hotmail.com
Status Recruiting
Phase N/A
Start date November 2014
Completion date December 2016